A Systematic Review of the Cost-Effectiveness Analyses of Anaplastic Lymphoma Kinase (ALK) Inhibitors in Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)-Reference-Cited by-同舟云学术

A Systematic Review of the Cost-Effectiveness Analyses of Anaplastic Lymphoma Kinase (ALK) Inhibitors in Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

Published:2023-06-03 Issue:8 Volume:41 Page:945-980
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:PharmacoEconomics

Author:

Chayab Lara^ORCID,Konstantelos Natalia,Leighl Natasha B.,Tadrous Mina,Wong William W. L.

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40273-023-01279-2.pdf

Reference83 articles.

1. Blackadar CB. Historical review of the causes of cancer. World J Clin Oncol. 2016;7(1):54–86. https://doi.org/10.5306/wjco.v7.i1.54.

2. Sadikovic B, Al-Romaih K, Squire JA, Zielenska M. Cause and consequences of genetic and epigenetic alterations in human cancer. Curr Genom. 2008;9(6):394–408. https://doi.org/10.2174/138920208785699580.

3. Minamoto T, Mai M, Ronai Z. Environmental factors as regulators and effectors of multistep carcinogenesis. Carcinogenesis. 1999;20(4):519–27. https://doi.org/10.1093/carcin/20.4.519.

4. Schwaederle M, Kurzrock R. Actionability and precision oncology. Oncoscience. 2015;2(10):779–80.

5. Cancer.Net. Lung cancer—non-small cell—statistics. June 25, 2012. https://www.cancer.net/cancer-types/lung-cancer-non-small-cell/statistics.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishing cost-effectiveness threshold in China: a community survey of willingness to pay for a healthy life year;BMJ Global Health;2024-01